GlassScriptPhysician profile
James D Torhorst
NPI 1336434075
$24,649.17
in general payments reported to CMS, 2019-2025
12 companies · $94.87 in 2025
The $94.87 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $4,500 · 2021: $3,490 · 2022: $222 · 2023: $171 · 2025: $94.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $265.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trilliant Surgical LLC. | $21,231.14 | 2019-2021 | |
| Arthrex, INC. | $1,262.00 | 2019 | |
| Great Lakes Orthopedics | $968.26 | 2019 | |
| Linvatec Corporation | $406.11 | 2019 | |
| Stryker Corporation | $247.80 | 2019-2022 | |
| Paragon 28, INC. | $168.17 | 2021-2023 | Phantom Metatarsal Shortening |
| Encore Medical, LP | $139.60 | 2022 | |
| Smith+Nephew, INC. | $120.84 | 2019-2025 | Grafix Pl, Stravix Mesh, Stravix Pl |
| Organogenesis INC. | $56.07 | 2022 | |
| Depuy Synthes Sales INC. | $26.19 | 2023 | Motoband |
| Treace Medical Concepts, INC. | $11.64 | 2022 | |
| Merck Sharp & Dohme LLC | $11.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Torhorst listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.